Literature DB >> 16390223

Renal failure and nephrocalcinosis associated with oral sodium phosphate bowel cleansing: clinical patterns and renal biopsy findings.

Gulfiliz Gonlusen1, Hulya Akgun, Atilla Ertan, Juan Olivero, Luan D Truong.   

Abstract

Acute renal failure (ARF) is rarely reported after bowel preparation with sodium phosphate. We report a patient with mild Crohn disease (in remission), without history of renal disease, and with normal baseline renal function, who developed ARF 14 days after bowel preparation for colonoscopy with oral sodium phosphate. A renal biopsy showed multifocal calcium phosphate deposition in the renal tubules against a background of diffuse chronic tubulointerstitial injury. Review of the literature suggested 2 distinct patterns of ARF in the context of sodium phosphate bowel cleansing. One pattern is characterized by ARF, which develops a few hours or days after sodium phosphate administration, as a component of a systemic syndrome associated with severe hyperphosphatemia and hypocalcemia. Correction of these electrolyte abnormalities was frequently associated with rapid recovery of renal function. The cause of ARF in this context was not clear because the favorable outcome negated the need for renal biopsy. In the second pattern, exemplified by the current patient, ARF was identified incidentally. These patients did not have any features of an acute syndrome immediately after sodium phosphate administration and presented much later (usually weeks) with mild, nonspecific symptoms. At the time of presentation, the serum calcium and phosphate levels were normal. The renal biopsies in each of these patients showed nephrocalcinosis as the possible cause of ARF. The renal failure improved at least partially in most of these patients, but persisted in rare cases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16390223     DOI: 10.5858/2006-130-101-RFANAW

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  27 in total

1.  A murine model of phosphate nephropathy.

Authors:  Philipp Eller; Kathrin Eller; Alexander H Kirsch; Josef J Patsch; Anna M Wolf; Andrea Tagwerker; Ursula Stanzl; Reinhard Kaindl; Volker Kahlenberg; Gert Mayer; Josef R Patsch; Alexander R Rosenkranz
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).

Authors:  Manfred Hauben; Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

3.  Indicators of safety compromise in gastrointestinal endoscopy.

Authors:  Mark Ram Borgaonkar; Lawrence Hookey; Roger Hollingworth; Ernst J Kuipers; Alan Forster; David Armstrong; Alan Barkun; Ron Bridges; Rose Carter; Chris de Gara; Catherine Dube; Robert Enns; Donald Macintosh; Sylviane Forget; Grigorios Leontiadis; Jonathan Meddings; Peter Cotton; Roland Valori
Journal:  Can J Gastroenterol       Date:  2012-02       Impact factor: 3.522

4.  Polyethylene glycol vs. sodium phosphate for bowel preparation: a treatment arm meta-analysis of randomized controlled trials.

Authors:  Ravi Juluri; George Eckert; Thomas F Imperiale
Journal:  BMC Gastroenterol       Date:  2011-04-14       Impact factor: 3.067

5.  Carbonated beverages and chronic kidney disease.

Authors:  Tina M Saldana; Olga Basso; Rebecca Darden; Dale P Sandler
Journal:  Epidemiology       Date:  2007-07       Impact factor: 4.822

6.  Serial monitoring of the physiological effects of the standard Pico-Salax® regimen for colon cleansing in healthy volunteers.

Authors:  Adam Rahman; Stephen J Vanner; Adrian Baranchuk; Lawrence C Hookey
Journal:  Can J Gastroenterol       Date:  2012-07       Impact factor: 3.522

7.  Colonoscopy preparation-induced disorders in renal function and electrolytes.

Authors:  Matilda Florentin; George Liamis; Moses S Elisaf
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

8.  Hyperphosphatemia after sodium phosphate laxatives in low risk patients: prospective study.

Authors:  Marcela-Noemi Casais; Guillermo Rosa-Diez; Susana Pérez; Elina-Noemi Mansilla; Susana Bravo; Francisco-Carlos Bonofiglio
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

9.  A prospective assessment of renal impairment after preparation for colonoscopy: oral sodium phosphate appears to be safe in well-hydrated subjects with normal renal status.

Authors:  M A Korsten; A M Spungen; A R Rosman; H R Ancha; J B Post; S Shaw; K K Hunt; R Williams; W A Bauman
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

10.  Incidence and outcome of acute phosphate nephropathy in Iceland.

Authors:  Vala Kolbrún Pálmadóttir; Hjalti Gudmundsson; Sverrir Hardarson; Margrét Arnadóttir; Thorvaldur Magnússon; Margrét B Andrésdóttir
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.